Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis

The WHO’s “Global tuberculosis report 2020” lists tuberculosis (TB) as one of the leading causes of death globally. Existing anti-TB therapy strategies are far from adequate to meet the End TB Strategy goals set for 2035. Therefore, novel anti-TB therapy protocols are urgently needed. Here, we propo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Juan, Fu, Liang, Li, Man, Chen, Yuyuan, Wang, Yi, Lin, Yi, Zhang, Hailin, Xu, Yan, Qin, Linxiu, Liu, Juncai, Wang, Weiyu, Hao, Jianlei, Liu, Shuyan, Zhang, Peize, Lin, Li, Alnaggar, Mohammed, Zhou, Jie, Zhou, Lin, Guo, Huixin, Wang, Zhaoqin, Liu, Lei, Deng, Guofang, Zhang, Guoliang, Wu, Yangzhe, Yin, Zhinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715986/
https://www.ncbi.nlm.nih.gov/pubmed/34975844
http://dx.doi.org/10.3389/fimmu.2021.756495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715986/
https://www.ncbi.nlm.nih.gov/pubmed/34975844
http://dx.doi.org/10.3389/fimmu.2021.756495

Ejemplares similares